Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

landing-hero-images1

ViiV gets EU approval for children’s HIV treatment

January 13, 2021 Research and Development EU, HIV, ViiV

ViiV Healthcare, the global specialist HIV company, has received marketing authorisation from the European Commission for Tivicay (dolutegravir) 5mg dispersible …
News
turkey_flag

Diurnal joins Er-Kim to distribute cortisol deficiency treatments in Turkey

January 13, 2021 Research and Development Diurnal, Diurnal Group, Er-Kim, Turkey

Diurnal Group, a specialty pharmaceutical company targeting patient needs in chronic endocrine diseases, has announced a distribution agreement with Er-Kim, …
News

Pfizer invests $25m in Vedanta BioSciences’ IBD treatment

January 13, 2021 Research and Development Pfizer, Vedanta Biosciences, inflammatory bowel disease

Pfizer has invested $25 million in Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases, …
News

Trial of potential new COVID-19 treatment begins in UK

January 13, 2021 Research and Development COVID-19, Synairgen, Vaccine

A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …
News
moderna_norwood_plant

Switzerland approves Moderna’s COVID-19 vaccine

January 13, 2021 Research and Development COVID-19, Moderna, Vaccine

Moderna has announced that its COVID-19 vaccine has been authorised for use on those aged 18 or older in Switzerland. …
News
richard_francis

Purespring Therapeutics to appoint Richard Francis as CEO

January 11, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …
Appointment
moderna_norwood_plant

EU approves Moderna’s COVID-19 vaccine

January 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …
News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 6, 2021 Research and Development COVID-19, Vaccine

In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …
News
who_flag

WHO recommends against 12-week delay for COVID-19 vaccine doses

January 6, 2021 Research and Development COVID-19, Vaccine, WHO

The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …
News
european_commission_web

Biogen’s IM Plegridy gets EU approval

January 6, 2021 Research and Development Biogen, multiple sclerosis

The European Commission has approved Biogen’s Plegridy (peginterferon beta-1a), a new intramuscular (IM) injection for the treatment of relapsing-remitting multiple …
News
angelini_pharma

Angelini Pharma to acquire Arvelle Therapeutics in $960 million deal

January 6, 2021 Research and Development Angelini Pharma, central nervous system

Angelini Pharma is set to acquire Arvelle Therapeutics, a biopharmaceutical company focused on bringing innovative treatments to patients suffering from …
News
astrazeneca_sign_sky

AstraZeneca’s Farxiga granted Priority Review by FDA

January 6, 2021 Research and Development AstraZeneca, FDA, farxiga

AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney …
News
herbert

Clinigen appoints Sam Herbert as Chief Operating Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
Appointment
screenshot_2021-01-05_puretech_announces_the_appointment_of_george_farmer_ph_d__as_chief_financial_officer_biospace

PureTech appoints George Farmer as Chief Financial Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …
Appointment
top_10_image_2_1_5

Pharmafile.com’s top 10 stories of 2020

December 23, 2020 Research and Development

The COVID-19 pandemic has, unsurprisingly, dominated the news this year. The site’s most popular articles of 2020, focused largely on …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025